Azithromycin for Child Survival in Niger: Programmatic Trial (AVENIR) (AVENIR)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05288023 |
|
Recruitment Status :
Not yet recruiting
First Posted : March 18, 2022
Last Update Posted : September 7, 2022
|
Sponsor:
University of California, San Francisco
Collaborators:
Bill and Melinda Gates Foundation
Ministry of Health, Niger
Information provided by (Responsible Party):
University of California, San Francisco
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Not yet recruiting |
|---|---|
| Estimated Primary Completion Date : | March 2026 |
| Estimated Study Completion Date : | March 2026 |
Publications: